CGC

Canopy Growth Corp
NASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

Key Statistics

Market Cap
$320.35M
P/E Ratio
—
EPS
$-0.45
Beta
2.37
52W High
$2.38
52W Low
$0.69
50-Day MA
$0.94
200-Day MA
$1.03
Dividend Yield
—
Profit Margin
-79.20%
Forward P/E
20.37
PEG Ratio
—

About Canopy Growth Corp

Canopy Growth Corporation is engaged in the production, distribution and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. The company is headquartered in Smiths Falls, Canada.

Official WebsiteUSAFY End: March

Fundamentals

Revenue (TTM)$293.63M
Gross Profit (TTM)$83.75M
EBITDA$-26.11M
Operating Margin-21.70%
Return on Equity-39.50%
Return on Assets-3.92%
Revenue/Share (TTM)$0.82
Book Value$1.15
Price-to-Book0.81
Price-to-Sales (TTM)1.09
EV/Revenue1.743
EV/EBITDA11014.10
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)12.50%
Shares Outstanding$423.04M
Float$422.10M
% Insiders0.18%
% Institutions7.84%

Historical Volatility

HV 10-Day
57.22%
HV 20-Day
48.09%
HV 30-Day
41.85%
HV 60-Day
41.37%
HV Rank
—

Volatility is currently expanding

Analyst Ratings

Consensus ($1.20 target)
2
Buy
6
Hold

Latest News

Canopy Growth's Smiths Falls Facility Becomes Canada's Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced that its Smiths Falls, Ontario facility (“Smiths Falls”) has received European Union Good Manufacturing Practice (“EU GMP”) certification for manufacturing and packaging activities from the Tübingen Regional Council (Regierungspräsidium Tübingen), Baden-Württemberg's com.

Business Wire10/13/2026Neutral
Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the appointment of Sebastian Blöte as Country Manager for Germany, effective October 1, 2026.Mr. Blöte will lead Canopy Growth's commercial strategy in Germany, with responsibility for expanding sales and strengthening execution across the market, deepening connections w.

Business Wire9/28/2026Neutral
Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced that, due to the requisite quorum not being present, its Annual General and Special Meeting of shareholders (the “Meeting”), scheduled for Friday, September 25, 2026, at 1:00 p.m. ET via live webcast, was convened and then adjourned. The Meeting will reconvene on Friday.

Business Wire9/25/2026Neutral
Canopy Growth Announces Extension of Proxy Voting Deadline for 2026 Annual General and Special Meeting

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced it has extended the proxy voting deadline for its upcoming Annual General and Special Meeting of shareholders (the “Meeting”) to 12:00 p.m. ET on Friday, September 25, 2026. The Meeting will be held later the same day, at 1:00 p.m. ET via live audio webcast at www.virtu.

Business Wire9/23/2026Neutral
Canopy Growth Expands European Medical Cannabis Supply Into the UK

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced that it will supply four Canadian-grown medical cannabis flower strains for distribution in the United Kingdom (the “UK”), expanding the reach of its international cannabis business into another European market. The Canadian-grown flower strains will be supplied to GROW.

Business Wire9/22/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CGC and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 10/17/2026